# Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

> **NCT00150787** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 250 (—)

## Conditions studied

- Epilepsy, Tonic-clonic

## Interventions

- **DRUG:** LEVETIRACETAM

## Key facts

- **NCT ID:** NCT00150787
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 250 (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150787, "Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00150787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*